Once a difficult market to crack, in recent years, China has relatively opened up its drug market, enacting reforms and speeding up approval time. Mumbai-headquartered Lupin is firming up plans to......
The company will now focus on specialty products in Japan; it is open to inorganic opportunities, especially in India. Pharma major Lupin has divested its entire stake in its Japanese subsidiary,......
This acquisition marks Lupin's foray into the Japanese branded market in-line with aspirations to build business globally. Kyowa Pharmaceutical Industry, drug major Lupin's Japanese subsidiary, has......
The government’s decision to stick to fiscal discipline has put pressure on the central bank to cut rates and spark investment into the economy. As the Union Budget 2016 seeps in, benchmark......
Talks to expand India-Japan trade pact remain a work in progress, even as trade deficit with Japan widens, says Nayanima Basu.The much-awaited review of the India-Japan comprehensive economic......